General Surgery
MD, Consultant Surgeon, Department of General Surgery, Shanghai Tongren Hospital, China
Doctor Peng Sun currently serves as the head of the Department of General Surgery at Shanghai Tongren Hospital. He completed his General Surgery training in Huashan Hospital in Shanghai. He has travelled to the Department of colorectal surgery in Mayo Clinic as a visiting surgeon in 2011. His main interest is the integrated application of ICG fluorescence imaging technology in colorectal cancer surgery, mainly used for intraoperative lymph node imaging, determining the blood supply of intestinal segments, and identifying lymphatic leakage, etc. He also interested in enhanced recovery after surgery measures, where clinical pathways have been developed and research is being conducted on the management of discharged patients.
Selected publications from PubMed
The association between sarcopenia and the prognosis of patients with high tumor burden hepatocellular carcinoma receiving hepatic artery infusion chemotherapy combined with lenvatinib and programmed death receptor-1 inhibitor: a multicenter, propensity score matching comparative study.
Li X, Dong Y, Chen W, Wang Y, Sun P, Chang X, Wu C, Wang D
Front Immunol. 2026;17:1782185 doi: 10.3389/fimmu.2026.1782185.
Investigation and validation of prognostic features associated with transient receptor potential channel genes in gastric cancer.
Zhao J, Kang H, Pan J, Sun P
PeerJ. 2026;14:e21468 doi: 10.7717/peerj.21468.
Association between nutrition-focused evidence-based nursing and post-operative nutritional status in patients undergoing colorectal cancer surgery.
Song LN, Gu YF, Jin N, Sun PM, Wei SZ, Zhang J
Front Nutr. 2026;13:1784385 doi: 10.3389/fnut.2026.1784385.
Long-term oncological outcomes of intracorporeal versus extracorporeal anastomosis in laparoscopic colon cancer surgery: A multicenter, retrospective cohort study.
Zhang M, Dong S, Chen F, Zhou H, Wang L, Hu X, Wei F, Sun P, Chen Y, Liang J, Liu Q
Chin Med J (Engl). 2026 Jul 10 doi: 10.1097/CM9.0000000000004156.
Delivery of a ZBP1 agonist enhances radiotherapy-induced antitumour immunity in hepatocellular carcinoma.
Liu H, He Q, Wang DX, Liu J, Qu Y, Zhang D, Sun P, Li H, Peng S, Li R, Dong Z, Zou J, Liu J, Li T
J Control Release. 2026 Jul 10;395:114991 doi: 10.1016/j.jconrel.2026.114991.
Help your network discover Dr. Peng Sun's clinical expertise.
